Breaking News Instant updates and real-time market news.

SMSI

Smith Micro

$31.00 /

+13 (+2.00%)

08:44
01/13/21
01/13
08:44
01/13/21
08:44

Smith Micro price target raised to $8 from $5.50 at B. Riley Securities

B. Riley Securities analyst Josh Nichols raised the firm's price target on Smith Micro to $8 from $5.50 and reiterates a Buy rating on the shares after management attended a virtual investor conference and disclosed that the company signed four new customer contracts in Q4. While details surrounding the new contracts were limited, management noted that the three new SafePath contracts are greenfield opportunities and the company is expected to provide further details after the forthcoming launch, Nichols tells investors in a research note. The analyst believes the new carrier wins serve as a testament to the quality of Smith Micro's offerings. The shares could support a "significantly higher" valuation multiple if new sales activity leads to additional wireless agreements, says Nichols.

  • 15

    Mar

SMSI Smith Micro
$31.00 /

+13 (+2.00%)

10/19/20 Lake Street
Smith Micro initiated with a Buy at Lake Street
10/19/20 Lake Street
Smith Micro initiated with a Buy at Lake Street
08/06/20 B. Riley Securities
Smith Micro price target lowered to $5.50 from $7.50 at B. Riley FBR
08/06/20 B. Riley Securities
Smith Micro price target lowered to $5.50 from $7.50 at B. Riley FBR

TODAY'S FREE FLY STORIES

Earnings
F.N.B. reports Q4 EPS 28c, consensus 24c » 19:09
01/19/21
01/19
19:09
01/19/21
19:09
FNB

F.N.B.

$11.09 /

+0.105 (+0.96%)

Reports Q4 net interest…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FNB F.N.B.
$11.09 /

+0.105 (+0.96%)

FNB F.N.B.
$11.09 /

+0.105 (+0.96%)

11/25/20 Stephens
Stephens downgrades F.N.B. to Equal Weight on relative outlook
11/25/20 Stephens
F.N.B. downgraded to Equal Weight from Overweight at Stephens
FNB F.N.B.
$11.09 /

+0.105 (+0.96%)

Hot Stocks
Colfax unit DJO acquires Trilliant SUrgical » 19:06
01/19/21
01/19
19:06
01/19/21
19:06
CFX

Colfax

$39.58 /

+0.78 (+2.01%)

DJO, LLC, a subsidiary of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CFX Colfax
$39.58 /

+0.78 (+2.01%)

CFX Colfax
$39.58 /

+0.78 (+2.01%)

01/13/21 Deutsche Bank
Colfax named 'Catalyst Call: Sell Idea' at Deutsche Bank
11/18/20 KeyBanc
Colfax price target raised to $44 from $36 at KeyBanc
11/09/20 UBS
Colfax upgraded to Buy from Neutral at UBS
09/15/20 UBS
Colfax initiated with a Neutral at UBS
CFX Colfax
$39.58 /

+0.78 (+2.01%)

Hot Stocks
Q BioMed granted Orphan Drug Designation for uttroside B » 18:50
01/19/21
01/19
18:50
01/19/21
18:50
QBIO

Q BioMed

$0.00 /

+ (+0.00%)

Q BioMed announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QBIO Q BioMed
$0.00 /

+ (+0.00%)

Hot Stocks
Logitech CEO: We're going to be right in the center of how people work » 18:45
01/19/21
01/19
18:45
01/19/21
18:45
LOGI

Logitech

$97.74 /

-3.21 (-3.18%)

In an interview on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LOGI Logitech
$97.74 /

-3.21 (-3.18%)

LOGI Logitech
$97.74 /

-3.21 (-3.18%)

12/21/20 Citi
Logitech price target raised to $110 from $105 at Citi
12/16/20 Morgan Stanley
Logitech price target raised to $106 from $100 at Morgan Stanley
11/12/20 Morgan Stanley
Logitech initiated with an Overweight at Morgan Stanley
11/05/20 Kepler Cheuvreux
Logitech upgraded to Buy from Hold at Kepler Cheuvreux
LOGI Logitech
$97.74 /

-3.21 (-3.18%)

LOGI Logitech
$97.74 /

-3.21 (-3.18%)

LOGI Logitech
$97.74 /

-3.21 (-3.18%)

LOGI Logitech
$97.74 /

-3.21 (-3.18%)

Hot Stocks
Nidec files patent infringement suit against Seagate » 18:32
01/19/21
01/19
18:32
01/19/21
18:32
NJDCY

Nidec

$0.00 /

+ (+0.00%)

, STX

Seagate

$61.20 /

+0.74 (+1.22%)

Nidec (NJDCY) filed a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STX Seagate
$61.20 /

+0.74 (+1.22%)

NJDCY Nidec
$0.00 /

+ (+0.00%)

STX Seagate
$61.20 /

+0.74 (+1.22%)

08:19 Today Northland
Seagate price target raised to $72 from $65 at Northland
08:08 Today Loop Capital
Seagate price target raised to $70 from $60 at Loop Capital
12/31/20 KeyBanc
Industry data points to flat monthly contract pricing for DRAM, says KeyBanc
12/28/20 Mizuho
Seagate price target raised to $65 from $54 at Mizuho
STX Seagate
$61.20 /

+0.74 (+1.22%)

STX Seagate
$61.20 /

+0.74 (+1.22%)

STX Seagate
$61.20 /

+0.74 (+1.22%)

Earnings
Azek sees Q1 adjusted EBITDA $46.2M-$51.1M vs. $33.8M last year » 18:18
01/19/21
01/19
18:18
01/19/21
18:18
AZEK

Azek

$42.25 /

+1.045 (+2.54%)

Sees Q1 net income…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZEK Azek
$42.25 /

+1.045 (+2.54%)

AZEK Azek
$42.25 /

+1.045 (+2.54%)

01/13/21 BMO Capital
Azek initiated with an Outperform at BMO Capital
12/31/20 William Blair
Azek, Trex among Blair's top Specialty Distribution ideas for 2021
12/04/20 DA Davidson
Azek price target raised to $39 from $33 at DA Davidson
12/04/20 B. Riley Securities
Azek price target raised to $46 from $43 at B. Riley Securities
AZEK Azek
$42.25 /

+1.045 (+2.54%)

  • 22
    Jan
  • 11
    Sep
  • 12
    Jun
AZEK Azek
$42.25 /

+1.045 (+2.54%)

AZEK Azek
$42.25 /

+1.045 (+2.54%)

AZEK Azek
$42.25 /

+1.045 (+2.54%)

Hot Stocks
Netflix says 'super proud' of free cash flow » 18:15
01/19/21
01/19
18:15
01/19/21
18:15
NFLX

Netflix

$501.85 /

+3.9 (+0.78%)

Says will remain…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

Earnings
Azek sees Q1 revenue $209.1M-$213.4M, consensus $201.6M » 18:10
01/19/21
01/19
18:10
01/19/21
18:10
AZEK

Azek

$42.25 /

+1.045 (+2.54%)

Q1 revenue outlook…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZEK Azek
$42.25 /

+1.045 (+2.54%)

AZEK Azek
$42.25 /

+1.045 (+2.54%)

01/13/21 BMO Capital
Azek initiated with an Outperform at BMO Capital
12/31/20 William Blair
Azek, Trex among Blair's top Specialty Distribution ideas for 2021
12/04/20 DA Davidson
Azek price target raised to $39 from $33 at DA Davidson
12/04/20 B. Riley Securities
Azek price target raised to $46 from $43 at B. Riley Securities
AZEK Azek
$42.25 /

+1.045 (+2.54%)

  • 22
    Jan
  • 11
    Sep
  • 12
    Jun
AZEK Azek
$42.25 /

+1.045 (+2.54%)

AZEK Azek
$42.25 /

+1.045 (+2.54%)

AZEK Azek
$42.25 /

+1.045 (+2.54%)

Hot Stocks
Netflix says not necessarily through the 'pull forward' of 2020 » 18:08
01/19/21
01/19
18:08
01/19/21
18:08
NFLX

Netflix

$501.85 /

+3.9 (+0.78%)

Says there is "so…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

Conference/Events
FDA PDUFA Date for Merck & Bayer Vericiguat is January 20, 2021  17:58
01/19/21
01/19
17:58
01/19/21
17:58
MRK

Merck

$83.18 /

-0.215 (-0.26%)

 
ShowHide Related Items >><<
MRK Merck
$83.18 /

-0.215 (-0.26%)

MRK Merck
$83.18 /

-0.215 (-0.26%)

01/06/21 Citi
Citi opens 'positive catalyst watch' on Merck
01/05/21 Citi
Citi boosts Merck target to $105, says may be most undervalued in pharma
12/22/20 Mizuho
Autolus, Arcus among top 2021 oncology picks at Mizuho
12/21/20 Alliance Global Partners
Alliance Global Partners keeps Buy on Sellas following data from trials
MRK Merck
$83.18 /

-0.215 (-0.26%)

MRK Merck
$83.18 /

-0.215 (-0.26%)

MRK Merck
$83.18 /

-0.215 (-0.26%)

MRK Merck
$83.18 /

-0.215 (-0.26%)

Periodicals
Biden administration weighs creating White House antitrust czar, Reuters says » 17:51
01/19/21
01/19
17:51
01/19/21
17:51
SPY

SPDR S&P 500 ETF Trust

$378.64 /

+2.95 (+0.79%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

The upcoming…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$378.64 /

+2.95 (+0.79%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$378.64 /

+2.95 (+0.79%)

01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
SPX S&P 500
$0.00 /

+ (+0.00%)

01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
SPY SPDR S&P 500 ETF Trust
$378.64 /

+2.95 (+0.79%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$378.64 /

+2.95 (+0.79%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$378.64 /

+2.95 (+0.79%)

SPX S&P 500
$0.00 /

+ (+0.00%)

On The Fly
Fly Intel: After-Hours Movers » 17:50
01/19/21
01/19
17:50
01/19/21
17:50
NFLX

Netflix

$501.85 /

+3.9 (+0.78%)

, MRUS

Merus

$24.68 /

+1.36 (+5.83%)

, GEVO

Gevo

$11.01 /

+4.62 (+72.30%)

, LAC

Lithium Americas

$26.80 /

+6.27 (+30.54%)

, SYRS

Syros Pharmaceuticals

$14.99 /

+0.88 (+6.24%)

, PERI

Perion Network

$13.96 /

+0.95 (+7.30%)

, BNGO

Bionano Genomics

$9.12 /

+0.705 (+8.38%)

, FULT

Fulton Financial

$14.79 /

+0.28 (+1.93%)

, JBHT

J.B. Hunt

$148.66 /

-2.99 (-1.97%)

, EXPI

eXp World Holdings

$79.69 /

+1.74 (+2.23%)

, SRNE

Sorrento Therapeutics

$9.43 /

-0.06 (-0.63%)

, ZION

Zions Bancorp

$49.35 /

+0.19 (+0.39%)

, CDNA

CareDx

$93.33 /

+5.18 (+5.88%)

Check out this evening's…

ShowHide Related Items >><<
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

MRUS Merus
$24.68 /

+1.36 (+5.83%)

GEVO Gevo
$11.01 /

+4.62 (+72.30%)

LAC Lithium Americas
$26.80 /

+6.27 (+30.54%)

SYRS Syros Pharmaceuticals
$14.99 /

+0.88 (+6.24%)

PERI Perion Network
$13.96 /

+0.95 (+7.30%)

BNGO Bionano Genomics
$9.12 /

+0.705 (+8.38%)

FULT Fulton Financial
$14.79 /

+0.28 (+1.93%)

JBHT J.B. Hunt
$148.66 /

-2.99 (-1.97%)

EXPI eXp World Holdings
$79.69 /

+1.74 (+2.23%)

SRNE Sorrento Therapeutics
$9.43 /

-0.06 (-0.63%)

CDNA CareDx
$93.33 /

+5.18 (+5.88%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
MRUS Merus
$24.68 /

+1.36 (+5.83%)

10:50 Today Roth Capital
Merus price target raised to $32 from $19 at Roth Capital
09/02/20 Roth Capital
Roth Capital keeps Buy on Merus after delay of cancer data
06/26/20 H.C. Wainwright
Merus initiated with a Buy at H.C. Wainwright
05/27/20
Fly Intel: Top five analyst downgrades
GEVO Gevo
$11.01 /

+4.62 (+72.30%)

08:31 Today Noble Capital
Gevo price target raised to $8.25 from $5 at Noble Capital
12/31/20 Noble Capital
Gevo price target raised to $5 from $3.50 at Noble Capital
02/06/20 Noble Capital
Gevo initiated with an Outperform at Noble Capital
LAC Lithium Americas
$26.80 /

+6.27 (+30.54%)

01/06/21 Canaccord
Lithium Americas price target raised to C$20 from C$11.50 at Canaccord
12/23/20 Stifel
Stifel starts Lithium Americas with Buy, sees 'attractive upside'
12/22/20 Stifel
Lithium Americas initiated with a Buy at Stifel
10/21/20 Roth Capital
Lithium Americas downgraded to Neutral from Buy at Roth Capital
SYRS Syros Pharmaceuticals
$14.99 /

+0.88 (+6.24%)

11/10/20 Brookline
Syros Pharmaceuticals initiated with a Buy at Brookline
11/05/20 Roth Capital
Syros' SY-1425+Aza could be competitive in multiple settings, says Roth Capital
11/04/20
Fly Intel: Top five analyst upgrades
11/04/20 H.C. Wainwright
Syros Pharmaceuticals upgraded to Buy from Neutral at H.C. Wainwright
PERI Perion Network
$13.96 /

+0.95 (+7.30%)

01/04/21 Lake Street
Perion Network price target raised to $18 from $12 at Lake Street
12/31/20 Sidoti
Perion Network price target raised to $14 from $12 at Sidoti
11/19/20
Fly Intel: Top five analyst initiations
11/19/20 Roth Capital
Perion Network initiated with a Buy at Roth Capital
BNGO Bionano Genomics
$9.12 /

+0.705 (+8.38%)

12/04/20 Roth Capital
Bionano Genomics downgraded to Neutral from Buy at Roth Capital
12/04/20 Roth Capital
Bionano Genomics downgraded to Neutral from Buy at Roth Capital
09/24/20 Ladenburg
Bionano Genomics initiated with a Buy at Ladenburg
04/08/20 Oppenheimer
Oppenheimer bullish on Bionano Genomics, initiates with an Outperform
FULT Fulton Financial
$14.79 /

+0.28 (+1.93%)

06/17/20 Raymond James
Fulton Financial upgraded to Outperform from Market Perform at Raymond James
06/01/20 Stephens
Fulton Financial initiated with an Equal Weight at Stephens
JBHT J.B. Hunt
$148.66 /

-2.99 (-1.97%)

06:10 Today Credit Suisse
J.B. Hunt upgraded to Outperform from Neutral at Credit Suisse
01/06/21 Citi
J.B. Hunt upgraded to Buy from Neutral at Citi
01/05/21 Stephens
J.B. Hunt price target raised to $167 from $155 at Stephens
11/30/20 Deutsche Bank
J.B. Hunt price target raised to $139 from $132 at Deutsche Bank
EXPI eXp World Holdings
$79.69 /

+1.74 (+2.23%)

11/10/20 DA Davidson
eXp World Holdings price target raised to $53 from $28 at DA Davidson
04/20/20 Stephens
Stephens ups CoreLogic, downgrades two others in real estate services shake-up
SRNE Sorrento Therapeutics
$9.43 /

-0.06 (-0.63%)

07/31/20 H.C. Wainwright
Sorrento Therapeutics price target raised to $30 from $24 at H.C. Wainwright
07/20/20 Dawson James
Sorrento antibody cocktail effort could move quickly, says Dawson James
05/26/20 Dawson James
Sorrento Therapeutics initiated with a Buy at Dawson James
ZION Zions Bancorp
$49.35 /

+0.19 (+0.39%)

01/07/21 B. Riley Securities
Zions Bancorp price target raised to $55 from $52 at B. Riley Securities
01/04/21 Barclays
Zions Bancorp downgraded to Equal Weight with $50 target at Barclays
01/04/21 Barclays
Zions Bancorp downgraded to Equal Weight from Overweight at Barclays
12/07/20 Evercore ISI
Zions Bancorp upgraded to Outperform from In Line at Evercore ISI
CDNA CareDx
$93.33 /

+5.18 (+5.88%)

01/12/21 Piper Sandler
CareDx price target raised to $93 from $62 at Piper Sandler
01/04/21 Craig-Hallum
CareDx price target raised to $94 from $66 at Craig-Hallum
12/17/20 BTIG
CareDx price target raised to $80 from $55 at BTIG
12/10/20 Raymond James
CareDx price target raised to $75 from $62 at Raymond James
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

MRUS Merus
$24.68 /

+1.36 (+5.83%)

GEVO Gevo
$11.01 /

+4.62 (+72.30%)

LAC Lithium Americas
$26.80 /

+6.27 (+30.54%)

SYRS Syros Pharmaceuticals
$14.99 /

+0.88 (+6.24%)

PERI Perion Network
$13.96 /

+0.95 (+7.30%)

BNGO Bionano Genomics
$9.12 /

+0.705 (+8.38%)

FULT Fulton Financial
$14.79 /

+0.28 (+1.93%)

JBHT J.B. Hunt
$148.66 /

-2.99 (-1.97%)

EXPI eXp World Holdings
$79.69 /

+1.74 (+2.23%)

ZION Zions Bancorp
$49.35 /

+0.19 (+0.39%)

CDNA CareDx
$93.33 /

+5.18 (+5.88%)

  • 21
    Jan
  • 21
    Jan
  • 20
    Jan
  • 20
    Jan
  • 20
    Jan
  • 20
    Jan
  • 08
    Jan
  • 11
    Jun
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

EXPI eXp World Holdings
$79.69 /

+1.74 (+2.23%)

SRNE Sorrento Therapeutics
$9.43 /

-0.06 (-0.63%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

MRUS Merus
$24.68 /

+1.36 (+5.83%)

GEVO Gevo
$11.01 /

+4.62 (+72.30%)

LAC Lithium Americas
$26.80 /

+6.27 (+30.54%)

SYRS Syros Pharmaceuticals
$14.99 /

+0.88 (+6.24%)

PERI Perion Network
$13.96 /

+0.95 (+7.30%)

BNGO Bionano Genomics
$9.12 /

+0.705 (+8.38%)

JBHT J.B. Hunt
$148.66 /

-2.99 (-1.97%)

EXPI eXp World Holdings
$79.69 /

+1.74 (+2.23%)

SRNE Sorrento Therapeutics
$9.43 /

-0.06 (-0.63%)

ZION Zions Bancorp
$49.35 /

+0.19 (+0.39%)

CDNA CareDx
$93.33 /

+5.18 (+5.88%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

LAC Lithium Americas
$26.80 /

+6.27 (+30.54%)

BNGO Bionano Genomics
$9.12 /

+0.705 (+8.38%)

JBHT J.B. Hunt
$148.66 /

-2.99 (-1.97%)

EXPI eXp World Holdings
$79.69 /

+1.74 (+2.23%)

SRNE Sorrento Therapeutics
$9.43 /

-0.06 (-0.63%)

ZION Zions Bancorp
$49.35 /

+0.19 (+0.39%)

Periodicals
FireEye releases tool for auditing networks after SolarWinds hack, ZDNet says » 17:45
01/19/21
01/19
17:45
01/19/21
17:45
FEYE

FireEye

$22.19 /

-0.01 (-0.05%)

, SWI

SolarWinds

$15.86 /

-0.16 (-1.00%)

, MSFT

Microsoft

$216.34 /

+3.73 (+1.75%)

FireEye (FEYE) has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FEYE FireEye
$22.19 /

-0.01 (-0.05%)

SWI SolarWinds
$15.86 /

-0.16 (-1.00%)

MSFT Microsoft
$216.34 /

+3.73 (+1.75%)

FEYE FireEye
$22.19 /

-0.01 (-0.05%)

01/12/21 Mizuho
FireEye price target raised to $21 from $17 at Mizuho
01/08/21 Morgan Stanley
FireEye price target raised to $19 from $14 at Morgan Stanley
01/08/21 Goldman Sachs
FireEye price target raised to $25 from $17 at Goldman Sachs
01/05/21 Piper Sandler
FireEye price target raised to $22 from $16 at Piper Sandler
SWI SolarWinds
$15.86 /

-0.16 (-1.00%)

01/14/21 JPMorgan
Investors with 'strong stomach for risk' should buy SolarWinds, says JPMorgan
01/11/21
Fly Intel: Top five analyst downgrades
01/11/21 Jefferies
SolarWinds downgraded to Hold on near-term challenges from hack at Jefferies
01/11/21 Barclays
SolarWinds price target lowered to $14 from $20 at Barclays
MSFT Microsoft
$216.34 /

+3.73 (+1.75%)

09:22 Today Morgan Stanley
Microsoft called 'a top stock for the recovery' at Morgan Stanley
01/13/21 KeyBanc
Windows upside could be limited with growth skewed to consumer, says KeyBanc
01/12/21 Morgan Stanley
CIO survey shows Microsoft 'dominance,' says Morgan Stanley
01/11/21 JPMorgan
Microsoft in-house chip co-designed by Marvell, says JPMorgan
FEYE FireEye
$22.19 /

-0.01 (-0.05%)

SWI SolarWinds
$15.86 /

-0.16 (-1.00%)

MSFT Microsoft
$216.34 /

+3.73 (+1.75%)

FEYE FireEye
$22.19 /

-0.01 (-0.05%)

SWI SolarWinds
$15.86 /

-0.16 (-1.00%)

MSFT Microsoft
$216.34 /

+3.73 (+1.75%)

FEYE FireEye
$22.19 /

-0.01 (-0.05%)

SWI SolarWinds
$15.86 /

-0.16 (-1.00%)

MSFT Microsoft
$216.34 /

+3.73 (+1.75%)

FEYE FireEye
$22.19 /

-0.01 (-0.05%)

MSFT Microsoft
$216.34 /

+3.73 (+1.75%)

Periodicals
YouTube extends Trump channel ban for extra week, CNBC says » 17:31
01/19/21
01/19
17:31
01/19/21
17:31
GOOG

Alphabet

$1,790.48 /

+54.11 (+3.12%)

, GOOGL

Alphabet Class A

$1,784.39 /

+56.98 (+3.30%)

Alphabet's YouTube…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOOG Alphabet
$1,790.48 /

+54.11 (+3.12%)

GOOG Alphabet
$1,790.48 /

+54.11 (+3.12%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 MoffettNathanson
Alphabet price target raised to $2,100 from $1,900 at MoffettNathanson
01/12/21 Cowen
Alphabet price target raised to $2200 from $1900 at Cowen
01/11/21 Jefferies
Yelp downgraded to Hold on 'full' valuation at Jefferies
GOOGL Alphabet Class A
$1,784.39 /

+56.98 (+3.30%)

07:19 Today KeyBanc
Alphabet price target to $2,060 from $1,970 at KeyBanc
GOOGL Alphabet Class A
$1,784.39 /

+56.98 (+3.30%)

GOOG Alphabet
$1,790.48 /

+54.11 (+3.12%)

GOOG Alphabet
$1,790.48 /

+54.11 (+3.12%)

GOOG Alphabet
$1,790.48 /

+54.11 (+3.12%)

GOOGL Alphabet Class A
$1,784.39 /

+56.98 (+3.30%)

GOOG Alphabet
$1,790.48 /

+54.11 (+3.12%)

Hot Stocks
UDR CEO sells 120K shares of common stock » 17:30
01/19/21
01/19
17:30
01/19/21
17:30
UDR

UDR

$38.68 /

-0.72 (-1.83%)

In a regulatory filing,…

In a regulatory filing, UDR disclosed that its CEO Thomas Toomey sold 120K shares of common stock on January 14th in a total transaction size of $4.66M, reducing his stake by about 9%.

ShowHide Related Items >><<
UDR UDR
$38.68 /

-0.72 (-1.83%)

UDR UDR
$38.68 /

-0.72 (-1.83%)

01/11/21 BMO Capital
UDR upgraded to Outperform from Market Perform at BMO Capital
12/15/20 Citi
UDR price target raised to $39 from $38 at Citi
11/20/20 Morgan Stanley
UDR upgraded to Overweight amid 'green shoots' at Morgan Stanley
11/20/20 Morgan Stanley
UDR upgraded to Overweight from Equal Weight at Morgan Stanley
UDR UDR
$38.68 /

-0.72 (-1.83%)

UDR UDR
$38.68 /

-0.72 (-1.83%)

Hot Stocks
David E Shaw reports 17.2% passive stake in Schrodinger » 17:27
01/19/21
01/19
17:27
01/19/21
17:27
SDGR

Schrodinger

$94.47 /

+3.72 (+4.10%)

David E Shaw disclosed a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SDGR Schrodinger
$94.47 /

+3.72 (+4.10%)

SDGR Schrodinger
$94.47 /

+3.72 (+4.10%)

11/23/20 BofA
BofA upgrades Schrodinger to Buy after 'major' collaboration announcement
11/23/20 BofA
Schrodinger upgraded to Buy from Neutral at BofA
10/12/20 Jefferies
Schrodinger upgraded to Buy from Hold at Jefferies
08/10/20
Schrodinger files to sell 4.5M shares of common stock
SDGR Schrodinger
$94.47 /

+3.72 (+4.10%)

  • 13
    Aug
  • 06
    Feb
SDGR Schrodinger
$94.47 /

+3.72 (+4.10%)

SDGR Schrodinger
$94.47 /

+3.72 (+4.10%)

Hot Stocks
US Foods awarded $390M Defense Logistics Agency contract for food distribution » 17:23
01/19/21
01/19
17:23
01/19/21
17:23
USFD

US Foods

$35.11 /

-0.56 (-1.57%)

US Foods has been awarded…

US Foods has been awarded a maximum $390M fixed-price with economic-price-adjustment, indefinite-quantity contract for full-line food distribution. This was a competitive acquisition with two responses received. This is a five-year contract with no option periods. Locations of performance are Florida, Cuba and Bahamas, with a January 18, 2026, ordering period end date. Using military services are Marine Corps, Air Force, Navy and Army. Type of appropriation is FY21 through FY26 defense working capital funds. The contracting agency is the Defense Logistics Agency.

ShowHide Related Items >><<
USFD US Foods
$35.11 /

-0.56 (-1.57%)

USFD US Foods
$35.11 /

-0.56 (-1.57%)

12/14/20 JPMorgan
US Foods price target raised to $35 from $30 at JPMorgan
12/02/20 Barclays
US Foods price target raised to $27 from $25 at Barclays
11/10/20 BMO Capital
US Foods upgraded to Outperform from Market Perform at BMO Capital
10/20/20 JPMorgan
US Foods price target raised to $30 from $26 at JPMorgan
USFD US Foods
$35.11 /

-0.56 (-1.57%)

USFD US Foods
$35.11 /

-0.56 (-1.57%)

Earnings
Pinnacle Financial reports Q4 EPS $1.58 ex-items, consensus $1.35 » 17:23
01/19/21
01/19
17:23
01/19/21
17:23
PNFP

Pinnacle Financial

$70.21 /

+0.3 (+0.43%)

Reports Q4 net…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PNFP Pinnacle Financial
$70.21 /

+0.3 (+0.43%)

PNFP Pinnacle Financial
$70.21 /

+0.3 (+0.43%)

01/04/21 Wells Fargo
Pinnacle Financial downgraded to Equal Weight from Overweight at Wells Fargo
12/15/20 JPMorgan
Pinnacle Financial upgraded to Overweight from Neutral at JPMorgan
11/16/20 Stephens
Pinnacle Financial resumed with an Overweight at Stephens
09/29/20 Truist
Truist raises price targets on select regional banks
PNFP Pinnacle Financial
$70.21 /

+0.3 (+0.43%)

Hot Stocks
SSR Mining sees FY21 gold production 720K-800K equivalent ounces » 17:23
01/19/21
01/19
17:23
01/19/21
17:23
SSRM

SSR Mining

$17.01 /

-0.05 (-0.29%)

SSR Mining announced full…

SSR Mining announced full year 2020 production results and 2021 outlook. In 2020, the company's four operating assets produced approximately 711,000 gold-equivalent ounces, delivering strong fourth quarter performance of approximately 220,000 gold-equivalent ounces. In 2021, the company expects to produce, on a consolidated basis, 720,000 to 800,000 gold-equivalent ounces at consolidated all-in sustaining costs of $1,050 to $1,110 per ounce. Rod Antal, President and CEO said, "2020 was a transformational year for SSR Mining as we successfully completed and integrated the merger with Alacer Gold, delivered a number of value-enhancing catalysts, and navigated the challenges presented by the COVID-19 pandemic. During this period of unprecedented change, the Company delivered on its 2020 production guidance and all four operating sites exited the year with strong operational momentum and clearly defined growth initiatives. Looking ahead to 2021, we are focused on continuing to generate peer leading free cash flow and returning capital to our shareholders, while prudently investing-in and optimizing our assets. This year we will be advancing and executing on our organic growth portfolio aimed at increasing production, reducing costs, and extending mine lives from our near-mine, low capital intensity pipeline. Our 2021 outlook builds on our 2020 performance and will continue to demonstrate our capability to sustain 700,000 to 800,000 gold-equivalent ounces of production for the next 5+ years."

ShowHide Related Items >><<
SSRM SSR Mining
$17.01 /

-0.05 (-0.29%)

SSRM SSR Mining
$17.01 /

-0.05 (-0.29%)

01/11/21 National Bank
SSR Mining price target lowered to C$41 from C$45 at National Bank
01/11/21 Scotiabank
SSR Mining price target lowered to C$38.50 from C$39.50 at Scotiabank
12/03/20 BofA
SSR Mining initiated with a Buy at BofA
12/02/20 National Bank
SSR Mining price target raised to C$45 from C$44 at National Bank
SSRM SSR Mining
$17.01 /

-0.05 (-0.29%)

SSRM SSR Mining
$17.01 /

-0.05 (-0.29%)

Earnings
Pinnacle Financial reports Q4 EPS $1.58 ex-items, consensus $1.35 » 17:21
01/19/21
01/19
17:21
01/19/21
17:21
PNFP

Pinnacle Financial

$70.21 /

+0.3 (+0.43%)

Reports Q4 net…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PNFP Pinnacle Financial
$70.21 /

+0.3 (+0.43%)

PNFP Pinnacle Financial
$70.21 /

+0.3 (+0.43%)

01/04/21 Wells Fargo
Pinnacle Financial downgraded to Equal Weight from Overweight at Wells Fargo
12/15/20 JPMorgan
Pinnacle Financial upgraded to Overweight from Neutral at JPMorgan
11/16/20 Stephens
Pinnacle Financial resumed with an Overweight at Stephens
09/29/20 Truist
Truist raises price targets on select regional banks
PNFP Pinnacle Financial
$70.21 /

+0.3 (+0.43%)

Syndicate
Ideanomics files automatic mixed securities shelf  17:18
01/19/21
01/19
17:18
01/19/21
17:18
IDEX

Ideanomics

$3.33 /

+0.16 (+5.05%)

 
ShowHide Related Items >><<
IDEX Ideanomics
$3.33 /

+0.16 (+5.05%)

IDEX Ideanomics
$3.33 /

+0.16 (+5.05%)

IDEX Ideanomics
$3.33 /

+0.16 (+5.05%)

IDEX Ideanomics
$3.33 /

+0.16 (+5.05%)

Syndicate
Gevo files automatic mixed securities shelf  17:17
01/19/21
01/19
17:17
01/19/21
17:17
GEVO

Gevo

$11.01 /

+4.62 (+72.30%)

 
ShowHide Related Items >><<
GEVO Gevo
$11.01 /

+4.62 (+72.30%)

GEVO Gevo
$11.01 /

+4.62 (+72.30%)

08:31 Today Noble Capital
Gevo price target raised to $8.25 from $5 at Noble Capital
12/31/20 Noble Capital
Gevo price target raised to $5 from $3.50 at Noble Capital
02/06/20 Noble Capital
Gevo initiated with an Outperform at Noble Capital
GEVO Gevo
$11.01 /

+4.62 (+72.30%)

GEVO Gevo
$11.01 /

+4.62 (+72.30%)

Hot Stocks
Google Cloud launches Product Discovery Solutions for Retail » 17:14
01/19/21
01/19
17:14
01/19/21
17:14
GOOG

Alphabet

$1,790.48 /

+54.11 (+3.12%)

, GOOGL

Alphabet Class A

$1,784.39 /

+56.98 (+3.30%)

In an earlier press…

In an earlier press release, Google Cloud announced, in part, the following: "Google Cloud announced the launch of Product Discovery Solutions for Retail, a suite of solutions built to help retailers around the globe enhance their ecommerce capabilities and deliver highly personalized consumer experiences in the first phase of their shopping journeys. With Google Cloud's Product Discovery Solutions for Retail, retailers can implement seamless search and recommendation capabilities that enhance consumer engagement and improve conversions across retailers' own digital properties. The global retail industry, which has grappled with the shift to online shopping for a decade, is now facing one of its most unpredictable periods to date, as businesses adapt to COVID-19...As the shift to online continues, smarter and more personalized shopping experiences will be even more critical for retailers to rise above their competition," said Carrie Tharp, vice president of retail and consumer at Google Cloud. "Retailers are in dire need of agile operating models powered by cloud infrastructure and technologies like artificial intelligence and machine learning (AI/ML) to meet today's industry demands. We're proud to partner with retailers around the world, and bring forward our Product Discovery offerings to help them succeed. Google Cloud's Product Discovery Solutions for Retail include: Now Generally Available, Recommendations AI enables retailers to deliver highly personalized product recommendations at scale and across all channels...Vision API Product Search allows retailers to adapt to how today's consumers are finding product inspiration and discovery whether that happens from retailer specific websites or on any social media platforms...Google Cloud Search for Retail, available in Private Preview, pulls from Google's deep understanding of user intent and context to provide retailers with high-quality product search functionality that can be embedded into their websites and mobile applications." Reference Link

ShowHide Related Items >><<
GOOG Alphabet
$1,790.48 /

+54.11 (+3.12%)

GOOG Alphabet
$1,790.48 /

+54.11 (+3.12%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 MoffettNathanson
Alphabet price target raised to $2,100 from $1,900 at MoffettNathanson
01/12/21 Cowen
Alphabet price target raised to $2200 from $1900 at Cowen
01/11/21 Jefferies
Yelp downgraded to Hold on 'full' valuation at Jefferies
GOOGL Alphabet Class A
$1,784.39 /

+56.98 (+3.30%)

07:19 Today KeyBanc
Alphabet price target to $2,060 from $1,970 at KeyBanc
GOOGL Alphabet Class A
$1,784.39 /

+56.98 (+3.30%)

GOOG Alphabet
$1,790.48 /

+54.11 (+3.12%)

GOOG Alphabet
$1,790.48 /

+54.11 (+3.12%)

GOOG Alphabet
$1,790.48 /

+54.11 (+3.12%)

GOOGL Alphabet Class A
$1,784.39 /

+56.98 (+3.30%)

GOOG Alphabet
$1,790.48 /

+54.11 (+3.12%)

Hot Stocks
Sorrento Therapeutics jumps 10% to $10.40 after COVID data announcement  17:09
01/19/21
01/19
17:09
01/19/21
17:09
SRNE

Sorrento Therapeutics

$9.43 /

-0.06 (-0.63%)

 
ShowHide Related Items >><<
SRNE Sorrento Therapeutics
$9.43 /

-0.06 (-0.63%)

SRNE Sorrento Therapeutics
$9.43 /

-0.06 (-0.63%)

07/31/20 H.C. Wainwright
Sorrento Therapeutics price target raised to $30 from $24 at H.C. Wainwright
07/20/20 Dawson James
Sorrento antibody cocktail effort could move quickly, says Dawson James
05/26/20 Dawson James
Sorrento Therapeutics initiated with a Buy at Dawson James
SRNE Sorrento Therapeutics
$9.43 /

-0.06 (-0.63%)

SRNE Sorrento Therapeutics
$9.43 /

-0.06 (-0.63%)

SRNE Sorrento Therapeutics
$9.43 /

-0.06 (-0.63%)

Hot Stocks
Sorrento Therapeutics to present STI-2020 data from mutation survey in COVID » 17:09
01/19/21
01/19
17:09
01/19/21
17:09
SRNE

Sorrento Therapeutics

$9.43 /

-0.06 (-0.63%)

The company states:…

The company states: "Sorrento Therapeutics announced that it will be presenting preliminary results from an ongoing SARS-CoV-2 mutation surveillance program for its neutralizing antibodies currently in clinical and pre-clinical development for treatment of patients with COVID-19 disease. Disclosed data will provide evidence of maintained binding potency by STI-2020 in in vitro assays including the Spike amino acid changes found in SARS-CoV-2 viruses of the B.1.1.7 lineage initially identified in the United Kingdom which has since been detected in ten U.S states. This is highly clinically relevant as it might signify that the STI-2020 antibody currently in clinical trials is not anticipated to behave differently against the new virus variant predicted by the CDC to potentially become the dominant virus variant infecting people in the US as early as March 2021. Sorrento will also provide early in vitro results of diminished STI-2020 binding potency in assays including Spike proteins derived from viruses of the B.1.351 lineage first identified in South Africa, but yet undetected in the United States. Additional neutralizing antibodies were identified that bind strongly to the B.1.1.7 and B.1.351 spike proteins and are under further analyses for neutralization activities both in vitro and in vivo. Upon further validation, the most promising antibody clones will be selected as potential candidates to be added as components of our COVI-SHIELD antibody cocktail as dictated by the continued emergence of mutations in clinical isolates. Sorrento believes it has in place highly potent antibodies against the most recent UK and South Africa viral variants for inclusion in COVI-SHIELD-2021."

ShowHide Related Items >><<
SRNE Sorrento Therapeutics
$9.43 /

-0.06 (-0.63%)

SRNE Sorrento Therapeutics
$9.43 /

-0.06 (-0.63%)

07/31/20 H.C. Wainwright
Sorrento Therapeutics price target raised to $30 from $24 at H.C. Wainwright
07/20/20 Dawson James
Sorrento antibody cocktail effort could move quickly, says Dawson James
05/26/20 Dawson James
Sorrento Therapeutics initiated with a Buy at Dawson James
SRNE Sorrento Therapeutics
$9.43 /

-0.06 (-0.63%)

SRNE Sorrento Therapeutics
$9.43 /

-0.06 (-0.63%)

SRNE Sorrento Therapeutics
$9.43 /

-0.06 (-0.63%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.